Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neutropenia 1Multiple Myeloma 1Malignant Solid Tumors 1Lymphoma, Non-Hodgkin 1Hematologic Neoplasms 1Breastcancer 1Bone Neoplasms 1

Interventions

pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Breastcancer × pegylated granulocyte colony-stimulating factor × Clear all
NCT02944604 2019-01-18

The Efficacy and Safety of PEG-rhG-CSF(Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy

Peking University

Phase 4 Completed
240 enrolled
Breast

Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡